CFvantage® Cystic Fibrosis Expanded Screen

Cystic Fibrosis Mutation Analysis, CF Expanded Mutation Carrier Screen,CFTR Expanded Mutation Screen,Cystic Fibrosis Expanded Panel,CF155 Mutations,CF Carrier Screen,CF Mutation Screen,Cystic Fibrosis Mutation Screen,Cystic Fibrosis Carrier Screen,CFTR Screen

Test Codes

EPIC: LAB1231901, Beaker: CFVANTAGE®, Quest: 92068

Department

Send Outs

Specimen Collection Criteria

Collect: One Lavender-top EDTA tube. (Minimum: 5.0 mL)

Physician Office/Draw Specimen Preparation

Do not freeze specimens. Maintain whole blood at room temperature (20-26°C or 68-78.8°F) prior to transport.

Preparation for Courier Transport

Transport: Whole blood at room temperature (20-26°C or 68-78.8°F).

Rejection Criteria

Specimens not collected and processed as indicated.

This test will only be performed once in a lifetime for the purposes of carrier screening.

In-Lab Processing

Do not centrifuge or freeze specimens.

Maintain whole blood at room temperature (20-26°C or 68-78.8°F) prior to transport.

Storage

Specimen Stability for Testing:

Whole Blood
Room Temperature (20-26°C or 68-78.8°F): 8 days
Refrigerated (2-8°C or 36-46°F): 8 days
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.

Laboratory

Sent to Quest Diagnostics, Wood Dale, IL.

Performed

Daily.
Results available in 7-8 days.

Reference Range

See report.

Test Methodology

Multiplex PCR, Next Generation Sequencing

Clinical Utility

CFvantage^® Cystic Fibrosis Expanded Screen – The CFvantage® Cystic Fibrosis Expanded Screen analyzes an expanded number of variants that have been proven to cause Cystic Fibrosis (CF). ACOG recommends screening for all women of reproductive age and for those with a personal or family history of CF.

CPT Codes

81220

Contacts

Last Updated

4/1/2026